Head of Operations
No salary listed
Expert
Bachelor's, MBA, PhD
Bern, Switzerland
HybridHybrid; work from the Bern headquarters as needed.
Business & StrategyBusiness Operations
About the job
Requirements
- A university degree in Business, Law, Engineering, or a relevant scientific field is required; an MBA or PhD is preferred given the technical nature of the products.
- A proven track record in operational integration within the MedTech Software industry or Health Information Technology is required.
- At least 10 years of leadership experience and a documented history of scaling a company from a small team to a mid-sized enterprise are required.
- Expertise in building and professionalizing operating systems to synchronize cross-functional teams and minimize departmental silos is required.
- A strong foundation in Information Architecture and Knowledge Management, with experience structuring digital workspaces, is required.
- Direct experience navigating complex regulatory pathways such as FDA or MDR, or highly regulated environments and managing internal Quality Management Systems, is required.
- The ability to manage multifaceted projects involving complex technical, legal, and human resource components is required.
- Current residency in Switzerland or willingness to relocate, with the ability to work from the Bern headquarters as needed, is required.
Responsibilities
- Direct the company’s core operational departments and provide executive leadership and mentorship to the heads of PMO, QRA, and HR.
- Implement a structured operating system to synchronize deployment across the organization and align technical development with commercial readiness.
- Optimize organizational design and workflows to help the dual-business model scale efficiently, professionalizing HR and operational processes without introducing inefficiencies.
- Modernize and govern the internal knowledge infrastructure and digital workspace to maintain a single, audited source of truth for corporate and technical data.
- Design and lead the company-wide objective-setting framework, translating strategic goals from the CEO and Board into measurable, synchronized departmental targets that eliminate conflicting priorities.
- Professionalize the vendor management lifecycle by overseeing selection, compliance, and performance of external service providers and partners.
- Act as the executive lead for legal compliance, interfacing with external counsel and EssilorLuxottica legal stakeholders to manage corporate risk in collaboration with finance and accounting.
- Support post-merger integration by harmonizing Ikerian’s operations with global corporate standards while maintaining organizational agility and innovation speed.
- Direct the Project Management Office to ensure disciplined execution of internal strategic initiatives and external client-facing projects.
- Oversee the HR and Talent Acquisition strategy to scale headcount and foster a high-performance culture that attracts and retains talent.
- Drive the high-level Regulatory and Quality strategy, ensuring the organization is operationally equipped to achieve and maintain global product clearances, including FDA 510(k)/De Novo and EU MDR.
About the company
RetinAI Medical provides an AI-powered healthcare data platform that harmonizes and analyzes unstructured medical data from formats like DICOM and proprietary systems. It helps medical professionals, researchers, and healthcare organizations manage, access, and analyze data to reveal insights about disease progression and treatment outcomes. The platform supports data collection, processing, visualization, and global collaboration through a subscription model and partnerships with clinics and research institutions. Its goal is to help healthcare providers make data-driven decisions that improve patient outcomes.
Company Size
11-50
Company Stage
Series B
Total Funding
$16.7M
Headquarters
Bern, Switzerland
Founded
2016
Get referred to RetinAI Medical
See people who can refer or advise you
Simplify's Take
What believers are saying
- LuxIA won CE-MDR Class IIb certification on April 30, 2025, expanding regulated use.
- June 24, 2024 MDR certification covered four devices, strengthening RetinAI's compliance moat.
- EssilorLuxottica's October 15, 2025 acquisition opens hospital, pharma, and retail eye-care channels.
What critics are saying
- Swiss study in April 2026 found server-hosting, anonymization, and interoperability barriers.
- RetinAI Discovery's automated AI modules remain research-use-only in the United States, limiting adoption.
- By 2027, EssilorLuxottica can absorb RetinAI into its stack, killing standalone identity.
What makes RetinAI Medical unique
- RetinAI Discovery holds FDA 510(k) clearance and CE marking, rare in ophthalmic AI.
- Its platform unifies OCT, fundus, and biomarker data for clinics and pharma partners.
- EssilorLuxottica acquired RetinAI on October 15, 2025, giving global distribution leverage.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Hybrid Work Options
- Professional Development Budget
- Conference Attendance Budget